Media Coverage

The New York Times 0

The Food and Drug Administration on Friday approved a first-of-a-kind drug that lowers artery-clogging cholesterol more than older drugs that have been prescribed for decades.An estimated 6.3 million U.S. patients cannot control their LDL levels with statins alone, according to medical surveys. And another 3.3 million are thought to be unable to tolerate statins due to side effects, but there are no formal criteria to identify these patients. As such, experts say more research is needed to define the group. “I think we need to be clear what qualifies for statin intolerance,” Dr. Neil Stone, a cardiologist at Northwestern University, said. “What moves you from an inexpensive, generic statin to a very expensive new drug that doesn’t have near the track record of the statin?”

Associated Press 0

The study’s lead author — Dr. Craig Garfield of Northwestern University — said he could only speculate about what’s behind the extra pounds.

“For men who become fathers, their whole life changes,” Garfield said. They may sleep less, exercise less, and experience more stress — all of which can lead to weight gain, he said.

The New York Times 0

Two studies published Tuesday lend support to controversial new cholesterol guidelines that could vastly increase the number of Americans advised to take cholesterol-lowering drugs called statins.

Events